Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer. - Aksoy O; Pencik J; Hartenbach M; Moazzami AA; Schlederer M; Balber T; Varady A; Philippe C; Baltzer PA; Mazumder B; Whitchurch JB; Roberts CJ; et al. (International journal of cancer, 2021)